Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opportunistic Autoimmune Diseases”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Looking for participantsNCT04339777
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativeImmune System Diseases+2 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT05236777
What this trial is testing

TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants

Who this might be right for
Multiple Sclerosis
Biogen 675
Testing effectiveness (Phase 2)Active Not RecruitingNCT03663933
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativePrimary T-cell Immunodeficiency Disorders+2 more
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT03922724
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T-cell LymphomasLymphoproliferative DisordersImmune System Diseases
National Cancer Institute (NCI) 91
Not applicableLooking for participantsNCT00867269
What this trial is testing

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Who this might be right for
Idiopathic CD4+ LymphocytopeniaCryptococcal MeningitisWarts
National Institute of Allergy and Infectious Diseases (NIAID) 950
Post-approval studies (Phase 4)Active Not RecruitingNCT03849131
What this trial is testing

Patient-Reported AutoImmunity Secondary to Cancer immunothErapy

Who this might be right for
Opportunistic Autoimmune Diseases
University Hospital, Strasbourg, France 905
Not applicableActive Not RecruitingNCT05605782
What this trial is testing

A Post-Authorization, Long-term Study of Ozanimod Real-world Safety

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bristol-Myers Squibb 9,000
Not applicableUnknownNCT00224562
What this trial is testing

The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists

Who this might be right for
Rheumatoid ArthritisCrohn's DiseaseAnkylosing Spondylitis+1 more
Assistance Publique - Hôpitaux de Paris
Not applicableStudy completedNCT02519413
What this trial is testing

Tecfidera Lymphocyte Chart Review

Who this might be right for
Multiple Sclerosis
Biogen 483
Testing effectiveness (Phase 2)Looking for participantsNCT02579967
What this trial is testing

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

Who this might be right for
Primary T-cell Immunodeficiency DisordersCommon Variable ImmunodeficiencyImmune System Diseases+2 more
National Cancer Institute (NCI) 354